This
page
is
part
of
the
FHIR
Specification
(v3.0.2:
STU
3).
(v3.3.0:
R4
Ballot
2).
The
current
version
which
supercedes
this
version
is
5.0.0
.
For
a
full
list
of
available
versions,
see
the
Directory
of
published
versions
.
Page
versions:
R4
R3
| Orders and Observations Work Group | Maturity Level : N/A | Ballot Status : Informative | Compartments : Device , Encounter , Patient , Practitioner |
This is the narrative for the resource. See also the XML or JSON format. This example conforms to the profile DiagnosticReport-Genetics (FHIR Specification Core)).
Gene DNAVariation Status Interpretation
BRCA1 Negative
BRCA2 185delAG Positive Pathogenic
Method: BRACAnalysis CDx Offered by Myriad Genetic Laboratories, Inc
Issued: 2015-05-26T15:30:10+01:00
FamilyMemeberHistory: Mother
Gene DNAVariation Status
BRCA2 185delAG Positive
Method: BRACAnalysis CDx Offered by Myriad Genetic Laboratories, Inc
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.